Early pharmacokinetic and pharmacodynamic effects of mixing lispro with glargine insulin: Results of glucose clamp studies in youth with type 1 diabetes

Diabetes Care

Volumn 33, Issue 5, 2010, Pages 1009-1012

  Cengiz, Eda ^a   Tamborlane, William V ^a   Martin Fredericksen, Melody ^a   Dziura, James ^a   Weinzimer, Stuart A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE; INSULIN LISPRO; ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLARGINE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; DRUG MECHANISM; DRUG MIXTURE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MAXIMUM ALLOWABLE CONCENTRATION; MONOTHERAPY; SCHOOL CHILD; SHIFT TO THE RIGHT; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT OUTCOME; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; DRUG EFFECT; DRUG INTERACTION; METABOLISM; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 1; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; GLUCOSE CLAMP TECHNIQUE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; YOUNG ADULT;

EID: 77954934352     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-2118     Document Type: Article

References (14)

1. Heinemann L, Linkeschova R, Rave K, Hompesch B, Sedlak M, Heise T. Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care 2000;23:644-649 (Pubitemid 30321545)
2. Lepore G, Dodesini AR, Nosari I, Trevisan R. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment. Diabetes Care 2003;26:1321-1322 (Pubitemid 36929300)
3. Rave K, Nosek L, Heinemann L, Frick A, Becker R. Time-action profile of the long-acting insulin analogue insulin glargine in comparison to NPH insulin in Japanese volunteers. Diabetes Metab 2003;29:430-431 (Pubitemid 37187112)
4. Lepore M, Pampanelli S, Fanelli C. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 2000;49:2142-2148
5. Lauritzen T, Pramming S, Gale EA, Deckert T, Binder C. Absorption of isophane (NPH) insulin and its clinical implications. Br Med J (Clin Res Ed) 1982;285:159-162 (Pubitemid 12079064)
6. Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004;27:1554-1558 (Pubitemid 38857425)
7. Sanofi-Aventis. Insert information for Lantus, glargine. Available from http://www.lantus.com/hcp/closing.aspx. Accessed 15 March 2010
8. Sanofi-Aventis. Lantus, data on file. Available from http://products. sanofi-aventis.us/lantus/lantus.html. Accessed 15 March 2010
9. Kaplan W, Rodriguez LM, Smith OE, Haymond MW, Heptulla RA. Effects of mixing glargine and short-acting insulin analogs on glucose control. Diabetes Care 2004;27:2739-2740 (Pubitemid 39441481)
10. Hassan K, Rodriguez LM, Johnson SE, Tadlock S, Heptulla RA. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes. Pediatrics 2008;121:e466-e472
11. Fiallo-Scharer R, Horner B, McFann K, Walravens P, Chase HP. Mixing rapidacting insulin analogues with insulin glargine in children with type 1 diabetes mellitus. J Pediatr 2006;148:481-484
12. Swan KL, Dziura JD, Steil GM, Voskanyan GR, Sikes KA, Steffen AT, Martin ML, Tamborlane WV, Weinzimer SA. Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy. Diabetes Care 2009;32:240-244
13. Mercodia. Insulin Assay Insert (Revised 2007). Available from http://www.mercodia.se/uploads/modulesMercodia/productsheets/ Iso-Insulin%20ELISA%20Product%20Sheet%20v%202.0.pdf. Accessed 15 March 2010
14. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223